1,131 results on '"Kullberg, Bart-Jan"'
Search Results
2. Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study
3. A comprehensive genetic map of cytokine responses in Lyme borreliosis
4. Genome-wide analyses in Lyme borreliosis: identification of a genetic variant associated with disease susceptibility and its immunological implications
5. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
6. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
7. Immunological Effects of Anti‒IL-17/12/23 Therapy in Patients with Psoriasis Complicated by Candida Infections
8. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
9. Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study
10. Towards personalized medicine: a scoping review of immunotherapy in sepsis.
11. Expectancies as predictors of symptom improvement after antimicrobial therapy for persistent symptoms attributed to Lyme disease
12. P29 Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and Phase 3 data
13. Lyme borreliosis : diagnosis and management
14. Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline
15. Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris
16. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
17. Classical Borrelia Serology Does Not Aid in the Diagnosis of Persistent Symptoms Attributed to Lyme Borreliosis: A Retrospective Cohort Study
18. Correction to “Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study”
19. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
20. 231. Outcomes by Baseline Pathogen and Susceptibility in the ReSTORE Phase 3 Trial of Rezafungin Once Weekly Compared with Caspofungin Once Daily in Patients with Candidemia and/or Invasive Candidiasis
21. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis
22. Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis
23. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
24. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus
25. Identifying platelet-derived factors as amplifiers ofB. burgdorferi-induced cytokine production
26. Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production
27. Human TLR10 is an anti-inflammatory pattern-recognition receptor
28. Cytokine Treatment of Fungal Infections
29. Recognition of fungal pathogens by Toll-like receptors
30. Invasive candidiasis
31. Adoption of a national antimicrobial guide (SWAB-ID) in the Netherlands
32. Serological and Clinical one year follow-up of Patients with Erythema migrans treated in a Romanian Infectious Disease Hospital
33. Immune defence against Candida fungal infections
34. Concerns about the external validity of the study ‘prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study’-authors´ reply
35. Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12
36. Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center
37. Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources
38. Defects in Host Defense Mechanisms
39. Belangenverstrengeling bij wetenschappelijke advisering
40. Reply to Anaissie and Nucci and to Cisneros et al
41. Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
42. Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia
43. Cytokine Gene Polymorphisms and the Outcome of Invasive Candidiasis: A Prospective Cohort Study
44. Genetic Variation in the Dectin-1/CARD9 Recognition Pathway and Susceptibility to Candidemia
45. Ocular Manifestations of Candidemia
46. Reply to Kontoyiannis
47. The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis
48. 1,25-dihydroxyvitamin D₃ Modulates Cytokine Production Induced by Candida albicans: Impact of Seasonal Variation of Immune Responses
49. Early Proinflammatory Cytokines and C-Reactive Protein Trends as Predictors of Outcome in Invasive Aspergillosis
50. Host impairments in patients with neoplastic diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.